National Alliance for Research on Schizophrenia and Depression

About National Alliance for Research on Schizophrenia and Depression

The National Alliance for Research on Schizophrenia and Depression centers its grantmaking on scientific research that aims to reduce suffering from mental illness, with a portfolio built around schizophrenia, depression, bipolar disorder, anxiety disorders, PTSD, OCD, autism spectrum disorder, addiction, suicide prevention, and early diagnostic tools. Its recent awards show a clear emphasis on major academic medical and research institutions, including Icahn School of Medicine at Mount Sinai and Columbia University, both of which appear repeatedly among the largest grants. The foundation also supports work at universities and hospitals such as UCLA, UCSF, Yale University School of Medicine, Stanford University, Harvard Medical School, and Massachusetts General Hospital. The grant program mix includes prizes and competitive research awards for individual researchers and teams, with named programs for early-career scientists, independent investigators, and established investigators. The award structure reaches from one-year recognition awards to two-year research grants, and the program descriptions point to neurobiological, behavioral, and clinical research relevant to serious brain and behavior disorders. Across the recent grant record, the organization’s support is directed to research institutions rather than individuals, and its funding footprint is national.

What National Alliance for Research on Schizophrenia and Depression Funds

In schizophrenia research, the foundation supports both recognition and project funding. Its Lieber Prize for Outstanding Achievement in Schizophrenia Research is a $50,000 award honoring discoveries in the field, while the BBRF Young Investigator Grants and Independent Investigator Grants support neurobiological research relevant to schizophrenia and related serious brain and behavior disorders. Thematically, depression and mood disorders are included alongside schizophrenia in the Young Investigator program, which also covers anxiety disorders and child and adolescent mental illnesses. For advanced investigators, the Independent Investigator Grants extend into major affective disorders and clinical research. The Distinguished Investigator Grants add support for innovative neurobiological and behavioral work, including research tied to severe mental illness and unique patient populations.

How National Alliance for Research on Schizophrenia and Depression Gives